Abstract:Rationale: SUMOylation regulates a plethora of biological processes, and its inhibitors are currently under investigation in clinical trials as anticancer agents. Thus, identifying new targets with site-specific SUMOylation and defining their biological functions will not only provide new mechanistic insights into the SUMOylation signaling but also open an avenue for developing new strategy for cancer therapy. MORC family CW-type zinc finger 2 (MORC2) is a newly identified chromatin-remodeling enzyme with an emerging role in the DNA damage response (DDR), but its regulatory mechanism remains enigmatic. Methods: In vivo and in vitro SUMOylation assays were used to determine the SUMOylation levels of MORC2. Overexpression and knockdown of SUMO-associated enzymes were used to detect their effects on MORC2 SUMOylation. The effect of dynamic MORC2 SUMOylation on the sensitivity of breast cancer cells to chemotherapeutic drugs was examined through in vitro and in vivo functional assays. Immunoprecipitation, GST pull-down, MNase, and chromatin segregation assays were used to explore the underlying mechanisms. Results: Here, we report that MORC2 is modified by small ubiquitin-like modifier 1 (SUMO1) and SUMO2/3 at lysine 767 (K767) in a SUMO-interacting motif dependent manner. MORC2 SUMOylation is induced by SUMO E3 ligase tripartite motif containing 28 (TRIM28) and reversed by deSUMOylase sentrin-specific protease 1 (SENP1). Intriguingly, SUMOylation of MORC2 is decreased at the early stage of DNA damage induced by chemotherapeutic drugs that attenuate the interaction of MORC2 with TRIM28. MORC2 deSUMOylation induces transient chromatin relaxation to enable efficient DNA repair. At the relatively late stage of DNA damage, MORC2 SUMOylation is restored, and SUMOylated MORC2 interacts with protein kinase CSK21 (casein kinase II subunit alpha), which in turn phosphorylates DNA-PKcs (DNA-dependent protein kinase catalytic subunit), thus promoting DNA repair. Notably, expression of a SUMOylation-deficient mutant MORC2 or administration of SUMO inhibitor enhances the sensitivity of breast cancer cells to DNA-damaging chemotherapeutic drugs. Conclusions: Collectively, these findings uncover a novel regulatory mechanism of MORC2 by SUMOylation and reveal the intricate dynamics of MORC2 SUMOylation important for proper DDR. We also propose a promising strategy to sensitize MORC2-driven breast tumors to chemotherapeutic drugs by inhibition of the SUMO pathway.

MORC2 Signaling Integrates Phosphorylation-Dependent, ATPase-coupled Chromatin Remodeling During the DNA Damage Response.

MORC2 Regulates DNA Damage Response Through a PARP1-dependent Pathway.

Dimerization of MORC2 Through Its C-terminal Coiled-Coil Domain Enhances Chromatin Dynamics and Promotes DNA Repair

MORC2 phosphorylation fine tunes its DNA compaction activity

ZNF506-dependent positive feedback loop regulates H2AX signaling after DNA damage

The MORC Family: New Epigenetic Regulators of Transcription and DNA Damage Response.

Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer

Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer

Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer

The MORC Family

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair

Mouse MORC3 is a GHKL ATPase That Localizes to H3K4me3 Marked Chromatin

Oligomerization of MDC1 Protein Is Important for Proper DNA Damage Response

A DNA damage-induced phosphorylation circuit enhances Mec1ATR-Ddc2ATRIP recruitment to Replication Protein A

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

A DNA damage–induced phosphorylation circuit enhances Mec1 <sup>ATR</sup> Ddc2 <sup>ATRIP</sup> recruitment to Replication Protein A

The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis

Identification and characterization of a human MORC2 DNA binding region that is required for gene silencing

Regulation of CHK1 by Mtor Contributes to the Evasion of DNA Damage Barrier of Cancer Cells

Biological Functions and Molecular Mechanisms of MORC2 in Human Diseases

Destabilization of microrchidia family CW‐type zinc finger 2 via the cyclin‐dependent kinase 1‐chaperone‐mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule‐targeting agents